within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AB34_Fomepizole;

model Fomepizole
  extends Pharmacolibrary.Drugs.ATC.V.V03AB34;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V03AB34</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Fomepizole is a competitive inhibitor of alcohol dehydrogenase, used primarily as an antidote in poisoning with methanol or ethylene glycol. It is FDA-approved and commonly used in emergency settings to prevent toxic metabolite formation in patients who have ingested these substances.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters obtained from healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Jairam, RK, et al., &amp; Mullangi, R (2019). Prediction of Human Pharmacokinetics of Fomepizole from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles. <i>AAPS PharmSciTech</i> 20(6) 221–None. DOI:<a href=\"https://doi.org/10.1208/s12249-019-1434-8\">10.1208/s12249-019-1434-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31214899/\">https://pubmed.ncbi.nlm.nih.gov/31214899</a></p></li><li><p>Druteika, DP, et al., &amp; Ensom, MH (2002). Role of fomepizole in the management of ethylene glycol toxicity. <i>Pharmacotherapy</i> 22(3) 365–372. DOI:<a href=\"https://doi.org/10.1592/phco.22.5.365.33187\">10.1592/phco.22.5.365.33187</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11899949/\">https://pubmed.ncbi.nlm.nih.gov/11899949</a></p></li><li><p>McMartin, KE, et al., &amp; Jacobsen, D (2012). Kinetics and metabolism of fomepizole in healthy humans. <i>Clinical toxicology (Philadelphia, Pa.)</i> 50(5) 375–383. DOI:<a href=\"https://doi.org/10.3109/15563650.2012.683197\">10.3109/15563650.2012.683197</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22554311/\">https://pubmed.ncbi.nlm.nih.gov/22554311</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fomepizole;
